82 FR 50654 - National Cancer Institute; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 210 (November 1, 2017)

Page Range		50654-50654
FR Document		2017-23814

Federal Register, Volume 82 Issue 210 (Wednesday, November 1, 2017)

[Federal Register Volume 82, Number 210 (Wednesday, November 1, 2017)]
[Notices]
[Page 50654]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-23814]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel Cancer Biomarkers & Biospecimens.
    Date: December 14, 2017.
    Time: 1:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove 9609 Medical 
Center Drive, Room 7W106 Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Reed A. Graves, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH 9609 Medical 
Center Drive, Room 7W106 Bethesda, MD 20892-9750, 240-276-6384 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: October 26, 2017.
    Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-23814 Filed 10-31-17; 8:45 am]
BILLING CODE 4140-01-P

50654 Federal Register / Vol. 82, No. 210 / Wednesday, November 1, 2017 / Notices

Scientific Review, National Institutes of Dated: October 27, 2017. DEPARTMENT OF HEALTH AND
Health, 6701 Rockledge Drive, Room 5156, Anna Snouffer, HUMAN SERVICES
MSC 7844, Bethesda, MD 20892, 301–435–
1042, capraramg@mail.nih.gov. Deputy Director, Office of Federal Advisory
Committee Policy. Substance Abuse and Mental Health
Name of Committee: Center for Scientific Services Administration
Review Special Emphasis Panel; PAR 17– [FR Doc. 2017–23813 Filed 10–31–17; 8:45 am]
142: International Research in Infectious BILLING CODE 4140–01–P Current List of HHS-Certified
Diseases, including AIDS (R01). Laboratories and Instrumented Initial
Date: December 5, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Testing Facilities Which Meet Minimum
DEPARTMENT OF HEALTH AND Standards To Engage in Urine Drug
Agenda: To review and evaluate grant HUMAN SERVICES
applications. Testing for Federal Agencies
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
National Institutes of Health AGENCY: Substance Abuse and Mental
Contact Person: Heidi B. Friedman, Ph.D., Health Services Administration, HHS.
Scientific Review Officer, Center for National Cancer Institute; Notice of ACTION: Notice.
Scientific Review, National Institutes of Closed Meeting
Health, 6701 Rockledge Drive, Room 1012A, SUMMARY: The Department of Health and
MSC 7770, Bethesda, MD 20892, 301–379– Pursuant to section 10(d) of the Human Services (HHS) notifies federal
5632, hfriedman@csr.nih.gov. Federal Advisory Committee Act, as agencies of the laboratories and
Name of Committee: Center for Scientific amended, notice is hereby given of the Instrumented Initial Testing Facilities
Review Special Emphasis Panel; Small following meeting. (IITF) currently certified to meet the
Business: Neuroscience Assay, Diagnostics standards of the Mandatory Guidelines
and Animal Model Development. The meeting will be closed to the
public in accordance with the for Federal Workplace Drug Testing
Date: December 5, 2017. Programs (Mandatory Guidelines).
Time: 8:00 a.m. to 7:00 p.m. provisions set forth in sections
A notice listing all currently HHS-
Agenda: To review and evaluate grant 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
applications. certified laboratories and IITFs is
as amended. The grant applications and
Place: Renaissance Washington DC, published in the Federal Register
the discussions could disclose
Dupont Circle, 1143 New Hampshire Avenue during the first week of each month. If
confidential trade secrets or commercial
NW., Washington, DC 20037. any laboratory or IITF certification is
property such as patentable material,
Contact Person: Susan Gillmor, Ph.D., suspended or revoked, the laboratory or
Scientific Review Officer, National Institutes and personal information concerning
IITF will be omitted from subsequent
of Health, Center for Scientific Review, 6701 individuals associated with the grant
lists until such time as it is restored to
Rockledge Drive, Bethesda, MD 20892, 301– applications, the disclosure of which
full certification under the Mandatory
435–1730, susan.gillmor@nih.gov. would constitute a clearly unwarranted
Guidelines.
Name of Committee: Center for Scientific invasion of personal privacy. If any laboratory or IITF has
Review Special Emphasis Panel; Toxicology Name of Committee: National Cancer withdrawn from the HHS National
and Digestive, Kidney and Urological
Institute Special Emphasis Panel Cancer Laboratory Certification Program (NLCP)
Systems AREA Review.
Biomarkers & Biospecimens. during the past month, it will be listed
Date: December 5, 2017.
Time: 10:00 a.m. to 6:00 p.m. Date: December 14, 2017. at the end and will be omitted from the
Agenda: To review and evaluate grant Time: 1:00 a.m. to 2:00 p.m. monthly listing thereafter.
applications. Agenda: To review and evaluate grant This notice is also available on the
Place: National Institutes of Health, 6701 applications. Internet at http://www.samhsa.gov/
Rockledge Drive, Bethesda, MD 20892 Place: National Cancer Institute, Shady workplace.
(Virtual Meeting). Grove 9609 Medical Center Drive, Room
Contact Person: Aiping Zhao, MD, FOR FURTHER INFORMATION CONTACT:
7W106 Rockville, MD 20850 (Telephone
Scientific Review Officer, Center for Giselle Hersh, Division of Workplace
Conference Call).
Scientific Review, National Institutes of Programs, SAMHSA/CSAP, 5600
Contact Person: Reed A. Graves, Ph.D.,
Health, 6701 Rockledge Drive, Room 2188, Scientific Review Officer, Research
Fishers Lane, Room 16N03A, Rockville,
MSC 7818, Bethesda, MD 20892–7818, (301)
Technology and Contract Review Branch,
Maryland 20857; 240–276–2600 (voice).
435–0682, zhaoa2@csr.nih.gov. SUPPLEMENTARY INFORMATION: The
Division of Extramural Activities, National
Name of Committee: Center for Scientific Department of Health and Human
Cancer Institute, NIH 9609 Medical Center
Review Special Emphasis Panel; Member Services (HHS) notifies federal agencies
Conflict: Glial and Neurovascular Diseases. Drive, Room 7W106 Bethesda, MD 20892–
9750, 240–276–6384 gravesr@mail.nih.gov. of the laboratories and Instrumented
Date: December 5, 2017.
Time: 1:00 p.m. to 3:00 p.m. (Catalogue of Federal Domestic Assistance Initial Testing Facilities (IITF) currently
Agenda: To review and evaluate grant Program Nos. 93.392, Cancer Construction; certified to meet the standards of the
applications. 93.393, Cancer Cause and Prevention Mandatory Guidelines for Federal
Place: National Institutes of Health, 6701 Research; 93.394, Cancer Detection and Workplace Drug Testing Programs
Rockledge Drive, Bethesda, MD 20892 Diagnosis Research; 93.395, Cancer (Mandatory Guidelines). The Mandatory
(Telephone Conference Call). Treatment Research; 93.396, Cancer Biology Guidelines were first published in the
Contact Person: Mary Custer, Ph.D., Federal Register on April 11, 1988 (53
Research; 93.397, Cancer Centers Support;
Scientific Review Officer, Center for FR 11970), and subsequently revised in
Scientific Review, National Institutes of 93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health, the Federal Register on June 9, 1994 (59
Health, 6701 Rockledge Drive, Room 4148,
sradovich on DSK3GMQ082PROD with NOTICES

MSC 7850, Bethesda, MD 20892, (301) 435– HHS) FR 29908); September 30, 1997 (62 FR
1164, custerm@csr.nih.gov. 51118); April 13, 2004 (69 FR 19644);
Dated: October 26, 2017.
(Catalogue of Federal Domestic Assistance
November 25, 2008 (73 FR 71858);
Melanie J. Pantoja,
Program Nos. 93.306, Comparative Medicine; December 10, 2008 (73 FR 75122); April
Program Analyst, Office of Federal Advisory 30, 2010 (75 FR 22809); and on January
93.333, Clinical Research, 93.306, 93.333,
Committee Policy. 23, 2017 (82 FR 7920).
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National [FR Doc. 2017–23814 Filed 10–31–17; 8:45 am] The Mandatory Guidelines were
Institutes of Health, HHS) BILLING CODE 4140–01–P initially developed in accordance with

VerDate Sep<11>2014 18:16 Oct 31, 2017 Jkt 244001 PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 E:\FR\FM\01NON1.SGM 01NON1

Document Created: 2017-11-01 02:03:04
Document Modified: 2017-11-01 02:03:04

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		December 14, 2017.
FR Citation		82 FR 50654

82 FR 50654 - National Cancer Institute; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 82, Issue 210 (November 1, 2017)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health